![]() | |
![]() | home about contact links |
![]() ![]() ![]() ![]() ![]() | |
July 02, 2007Congress v. Global HealthIn today's Wall Street Journal, Ronald Cass takes issue with a number of Congressional Democrats who issued a letter chiding the U.S. Trade Representative for putting Thailand on a list of IP infringers. Cass says that: "Henry Waxman and 34 other House Democrats wrote a letter to U.S. Trade Representative Susan Schwab late last month demanding that she rescind her decision to put Thailand on the "Special 301" Priority Watch List of nations violating intellectual property rights. Cass' points are well taken. The protection of intellectual property rights encourages innovation in knowledge-intensive industries like pharmaceuticals where barriers to market entry (i.e, FDA regulations) are severe and the costs of developing new products are high. Without the guarantee of a substantial period of monopoly protection (and high initial prices) for their products, companies would be unable to attract the investors and capital required to create new pharmaceuticals. If policymakers and philanthropists are concerned about poor countries being able to afford new medicines (like AIDS drugs) the Gates Foundation and the President's Emergency Plan for AIDS Relief -or the Open Society Institute - can step in to buy drugs on their behalf. Sabotaging intellectual property rights in middle-income countries like Thailand sends a signal to investors that the returns on their investment in new medicines will be limited by political expedience. Fewer new medicines tomorrow will hurt poor nations and rich nations alike - surely not an outcome that Congress intends to promote. Posted by Paul Howard at July 2, 2007 05:58 PM |
|
![]() | ||
| home spotlight commentary research events news about contact links archives | ||